New ways in Parkinson's research: funding for innovative approaches
New ways in Parkinson's research: funding for innovative approaches
Monday, 22.07.2024
A breakthrough in Parkinson's research: Possibilities through epigenetic approaches
Dr. rer. Hum. Biol. Björn-Hergen Laabs from the Institute for Medical Biometry and Statistics receives Else Kröner-Fresenius for his research on X-chromosomal dystonia-Parkinson syndrome (XDP). Photo: Lea Louisa Kronziel/IBMS
Research on X-chromosomal dystonia Parkinson syndrome (XDP), a hereditary illness, receives a new impulse from the work of Dr. Björn-Hergen Laabs at the University of Lübeck. With a generous support of around 300,000 euros from the Else Kröner-Fresenius Foundation, the project aims to expand both the understanding and the possible treatment options of this complex illness.
research on environmental factors and genetic activity
The research project examines how environmental factors influence genetic activity in XDP patients. This is of great importance, since the disease occurs primarily in men in the Philippines and the symptoms, such as involuntary muscle tensions, often reduce the quality of life of those affected considerably. The exact trigger of the symptoms have not yet been fully clarified, which is why Dr. Laabs represents a promising approach.
new knowledge through artificial intelligence
A central element of research is the use of artificial intelligence to analyze complex genetic and epigenetic relationships. The methods of AI are intended to help to better predict the age of the XDP affected. Dr. Laabs explains: "I would like to find out whether XDP patients agree faster than healthy people and whether epigenetic profiles can be used to predict the age of illness."
The role of epigenetics in the understanding of illness
The term epigenetics refers to the changes in genetic activity, which are not due to changes in the DNA sequence itself. In this case, the epigenetic changes could have a decisive influence on how difficult or easily the symptoms of those affected occur. These findings could offer a new perspective for future therapy approaches.
personal background of Dr. Laabs
dr. Laabs has completed his academic training in medical mathematics and life sciences at the University of Lübeck and specialized in the genetic background of XDP. During his career, he has already received several awards, including the Medical Science Award and the Junior Promotion for his innovative work in the field of mechanical learning.
meaning for the future of Parkinsonial research
This research could not only offer direct advantages for those affected of the XDP, but also show new methods for analysis and possibly to treat other forms of Parkinson's disease. The project represents an important step in research into rare neurological diseases and could provide future -oriented knowledge for science and the medical community.
Contact:
dr. rer. Hum. Biol. Björn-Hergen Laabs
Institute for Medical Biometry and Statistics
University zu Lübeck
Tel: 0451 500-50623
E-Mail: B.Laabs (at) Uni-Luebeck (dot) de
- Nag